Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Bulky Malignancies”

15 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 15 results

Testing effectiveness (Phase 2)Looking for participantsNCT06416007
What this trial is testing

Lattice Radiotherapy for Dose-Escalated Palliation of Bulky Tumors

Who this might be right for
CancerMetastatic CancerLocally Advanced+2 more
University of Cincinnati 37
Testing effectiveness (Phase 2)Ended earlyNCT00765570
What this trial is testing

Study of Advanced Bulky Malignancies With Spatially Fractioned Radiation Therapy

Who this might be right for
Advanced Bulky Malignancies
Summa Health System 12
Not applicableUnknownNCT01680523
What this trial is testing

Radical Hysterectomy Followed by Tailored Adjuvant Therapy Versus Primary Chemoradiation Therapy in Bulky Early-stage Cervical Cancer (KGOG 1029)

Who this might be right for
Cervical Cancer
Asan Medical Center 409
Testing effectiveness (Phase 2)Active Not RecruitingNCT02934568
What this trial is testing

Ribociclib (LEE011) Rollover Study for Continued Access

Who this might be right for
Continued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid Malignancies
Novartis Pharmaceuticals 22
Large-scale testing (Phase 3)Active Not RecruitingNCT02466971
What this trial is testing

Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers

Who this might be right for
Advanced Vaginal AdenocarcinomaAdvanced Vaginal Adenosquamous CarcinomaAdvanced Vaginal Squamous Cell Carcinoma+18 more
National Cancer Institute (NCI) 450
Not applicableUnknownNCT02333110
What this trial is testing

GRID Therapy as Palliative Radiation for Patients With Advanced and Symptomatic Tumors

Who this might be right for
Patients With Symptomatic or Bulky Tumors (More Than 8 cm) or With Tumors Resistant to Radiation
Sir Mortimer B. Davis - Jewish General Hospital 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07041788
What this trial is testing

Iparomlimab and Tuvonralimab Combined With SFRT and Definitive Chemoradiotherapy in Locoregionally Advanced Bulky HNSCC

Who this might be right for
Cancer
Second Affiliated Hospital of Nanchang University 25
Large-scale testing (Phase 3)Looking for participantsNCT05699655
What this trial is testing

Tislelizumab Combined With Apatinib and Oxaliplatin Plus S1 Vs Oxaliplatin Plus S1 as Neoadjuvant Therapy for Borrmann IV、Large Borrmann III Type and Bulky N Positive Advanced Gastric Cancer

Who this might be right for
Immunotherapy Gastrict Cancer
Fujian Cancer Hospital 130
Testing effectiveness (Phase 2)Study completedNCT05223088
What this trial is testing

Tislelizumab Combined With Apatinib and Oxaliplatin Plus S1 as Neoadjuvant Therapy for Borrmann IV、Large Borrmann III Type and Bulky N Positive Advanced Gastric Cancer

Who this might be right for
ImmunotherapyGastrict Cancer
Fujian Cancer Hospital 40
Testing effectiveness (Phase 2)Ended earlyNCT03661567
What this trial is testing

Methylprednisolone After Split-course Chemoradiotherapy For Bulky Local Advanced None-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Sun Yat-sen University 52
Early research (Phase 1)Ended earlyNCT03114319
What this trial is testing

Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors

Who this might be right for
Advanced EGFR Mutant Non Small Cell LungCancer (NSCLC)KRAS G12-mutant NSCLCEsophageal Squamous Cell Cancer (SCC)+4 more
Novartis Pharmaceuticals 227
Testing effectiveness (Phase 2)Ended earlyNCT01708161
What this trial is testing

A Phase Ib/II Study of the Combination of BYL719 Plus AMG 479 in Adult Patients With Selected Solid Tumors

Who this might be right for
PIK3CA Mutated Advanced Solid TumorsPIK3CA Amplified Advanced Solid Tumors
Novartis Pharmaceuticals 47
Testing effectiveness (Phase 2)Study completedNCT01054781
What this trial is testing

Intensified 1st Cycle Rituximab Plus 8th Cycles of R-CHOP Chemotherapy in Patients With Advanced or Bulky CD20+ Diffuse Large B-cell Lymphoma (DLBCL)

Who this might be right for
Diffuse Large B-cell Lymphoma (DLBCL)
Samsung Medical Center 91
Testing effectiveness (Phase 2)UnknownNCT05888402
What this trial is testing

Induction Chemotherapy and Toripalimab Followed by Chemoradiotherapy for Large-volume Local Advanced NSCLC

Who this might be right for
Local Advanced Non-small Cell Lung Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 50
Large-scale testing (Phase 3)Study completedNCT00112931
What this trial is testing

Rituximab in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
University College, London 462